Consistent with LOXL2 promotion of tumor development and progression, LOXL2 knockdown and overexpression in human PDAC cell lines suggest oncogenic roles of LOXL2 in tumor growth and liver metastasis both in vitro and in vivo. This evidence concerns the gene LOXL2 and neoplasm.